Vitamin E Protection from/ Potentiation of the Cytogenetic Toxicity of Cisplatin in Swiss Mice

References

• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 26: Some antineoplastic and immunosuppressive agents 1981; International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: an update of selected IARC Monographs from volumes 1-42 (Suppl. 6) 1987; International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 50: Pharmaceutical Drugs 1990; International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• Marselos M, Vainio H. Carcinogenic properties of pharmaceutical agents evaluated in the IARC Monographs programme. Carcinogenesis 1991; 12 (10): 1751–1766.
   PubMed Web of Science ®Google Scholar
• Ferguson LR. Mutagenic properties of anticancer drugs. In: Ponder BAJ, Waring MJ, eds. The Genetics of Cancer. Lancaster, Kluwer Scientific Publishers, 1995: 177-216.
   Google Scholar
• Curtis RE, Boice JD, Moloney WC, Ries LG, Flannery JT. Leukaemia following chemotherapy for breast cancer. Cancer Res 1990; 50: 2741–2746.
   PubMed Web of Science ®Google Scholar
• Pratt CB, Pui CH. Second tumours after treatment with anticancer drugs. In: Powis G, Hacker MP, eds. The Toxicity of Anticancer Drugs. New York, Pergamon Press, 1991: 28-43.
   Google Scholar
• Coleman CN, Williams CJ, Fluit A, Glastein EJ, Rosenberg SA, Kaplan HS. Haematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med 1977; 297: 1249–1252.
   PubMed Web of Science ®Google Scholar
• de Serres FJ, Matsushima T. Meeting report: Mutagenesis and carcinogenesis by nitropyrenes and cancer chemotherapeutics. Mutat Res 1986; 64: 3–6.
   Web of Science ®Google Scholar
• William CJ, Whitehouse JMA. Cis-platinum: A new anticancer agent. Br Med J 1979; 1: 1689–1691.
   PubMedGoogle Scholar
• Rosenberg B. Fundamental studies with cisplatin. Cancer 1985; 55: 2303–2316.
   PubMed Web of Science ®Google Scholar
• Greene MH. Is cisplatin a human carcinogen? J Natl Cancer Inst 1992; 84: 306–312.
   PubMedGoogle Scholar
• Lawley PD, Phillips DH. DNA adducts from chemother-apeutic agents. Mutat Res 1996; 355: 13–40.
   PubMed Web of Science ®Google Scholar
• Sanderson BJS, Ferguson LR, Denny WA. Mutagenic and carcinogenic properties of platinum-based anticancer drugs. Mutat Res 1996; 355: 59–70.
   PubMed Web of Science ®Google Scholar
• Choudhury RC, Jagdale MB, Misra S. Cytogenetic toxi-city of cisplatin in bone marrow cells of Swiss mice. J Chemother 2000; 12 (2): 173–182.
   PubMed Web of Science ®Google Scholar
• Adler I-D, El-Tarras A. Clastogenic effects of cis-diammine-dichloroplatinum. I. Induction of chromosomal aberrations in somatic and germinal cells of mice. Mutat Res 1989; 211: 131–137.
   Google Scholar
• Alder ID, El-Tarras A. Clastogenic effects of cis-diamminedi-chloroplatinum. II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice. Mutat Res 1990; 243: 173–178.
   Google Scholar
• Biswas T, Chakrabarti S. Germ cell cytotoxicity in tumour-bearing mouse subjected to single therapeutic dose of cis-diammine-dichloroplatinum (II), Curr Sci 1993; 65: 82–84.
   Google Scholar
• Choudhury RC, Jagdale MB, Misra S. Potential transmission of the cytogenetic effects of cisplatin in the male germline cells of Swiss mice. J Chemother 2000; 12 (4): 352–359.
   PubMed Web of Science ®Google Scholar
• Noda N, Wakasugi H. Cancer and oxidative stress. JMAJ. 2001; 44 (12): 535–539.
   Google Scholar
• Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998; 9: 1331–1337.
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Lin X, Costa M. Protective effect of vita-min E against chromosomal aberrations and mutation induced by sodium chromate in Chinese hamster. Mutat Res 1991; 260: 19–23.
   PubMed Web of Science ®Google Scholar
• Lin X, Sugiyama M. Costa M. Differences in the effect of vitamin E on nickel sulfide or nickel chloride-induced chro-mosomal aberrations in mammalian cells. Mutat Res 1991; 260: 159–164.
   Google Scholar
• Rana K, Sood A, Malhotra N. Radioprotection of chick thymus by vitamin E. Ind J Exp Biol 1993; 31: 847–849.
   PubMedGoogle Scholar
• Geetha A, Shyamala Devi. Influence of a-tocopherol on the antitumour potential and the toxicity of doxorubicin. Curr Sci 1993; 64 (5): 318–320.
   Web of Science ®Google Scholar
• El-Nahas SM, Mattar FE, Mohamed AA. Radioprotective effect of vitamin C and E. Mutat Res 1993; 301: 143–147.
   PubMed Web of Science ®Google Scholar
• Tavan E, Maiziere S, Narbonne JF, Cassand P. Effects of vitamins A and E on methylazoxymethanol-induced mutage-nesis in Salmonella typhimurium strain TA 100. Mutat Res 1997; 377: 231–237.
   PubMed Web of Science ®Google Scholar
• Konopacka M, Widel M, Rzeszowska-Wolny J. Modifying effect of vitamins C, E and beta-carotene against gammaray induced DNA damage in mouse cells. Mutat Res 1998; 417: 85–94.
   PubMed Web of Science ®Google Scholar
• Choudhury RC, Hasan A, Mahanty V. Effects of mer-curic chloride on mitotic, meiotic chromosomes and sperm in mice. Biol Zent bl 1995; 114: 369–377.
   Google Scholar
• Pinto A, Lippard SJ. Binding of the antitumor drug cis-diamminedi-chloroplatinum-II (cisplatin) to DNA. Biochem Biophys Acta 1985; 780: 167–180.
   PubMed Web of Science ®Google Scholar
• Zwelling LA, Bradley MO, Sharkey NA, Anderson T, Kohn KW. Mutagenicity, cytotoxicity and DNA cross linking in V79 Chinese hamster cells treated with cis- and trans-pt (II) diamminedichloride. Mutat Res 1979; 67: 271–280.
   PubMed Web of Science ®Google Scholar
• Fichtinger-Schepman AMJ, Lohman PHM, Berends F. Interaction of antitumor drug cisplatin with DNA in vitro and in vivo. In: Schmahl D Kaldor JM, eds. Carcinogenicity of Alkylating Cytostatic Drugs, Lyon: IARC Scientific Publication, IARC, 1986; 78: 83–89.
   PubMedGoogle Scholar
• Poirier MC, Reed E, Shamkhani H, Tarone RE, Gupta SB. Plantinum-DNA interactions in human tissues measured by cisplatin DNA enzyme linked immunosorbent assay and atomic absorbance spectroscopy. Environ Health Perspect 1993; 99: 149–154.
   PubMed Web of Science ®Google Scholar
• Poirier MC, Reed E, Zwelling LA, Ozols RF, Litterst CL, Yuspa SA. Polyclonal antibodies to quantitate cis-diamminedichloroplatinum-II DNA adducts in cancer patients and animal models. Environ Health Prospect 1995; 62: 89–94.
   Google Scholar
• Bouyadi K. Salles B. Influence of DNA supercoiling on cisplatin toxicity in Escherichia coli K-12. Mutat Res 1995; 348: 25–31.
   PubMed Web of Science ®Google Scholar
• Brandsma JA, de Ruijter M, Visse R, et al. The in vitro more efficiently repaired cisplatin adduct cis-pt.GG in in vivo a more mutagenic lesion than the relative slowly repaired cis-pt.GCG adduct. Mutat Res 1996; 362: 29-40.
   Google Scholar
• Rice JA, Crothers DM, Pinto AL, Lippard SJ. The major adduct of the antitumor drug cis-diamminedichloroplat-inum-II with DNA bends and duplex by 40° toward the major groove. Proc Natl Acad Sci USA 1988; 85: 4158.
   PubMed Web of Science ®Google Scholar
• Au11 JL, Allen RL, Bapat AR, Daron HH, Friedman ME, Wilson JF. The effects of platinum complexes on seven enzymes. Biochim Biophys Acta 1979; 57: 352–358.
   Google Scholar
• Yu BP. Cellular defenses against damage from reactive oxygen species. Physiolog Rev 1994; 73: 139–162.
   Google Scholar
• Lachance PA. Future vitamin and antioxidant RDAs for health promotion. Prevent Med 1996; 25: 46–47.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay U, Das D, Banerjee RK. Reactive oxy-gen species: Oxidative damage and pathogenesis. Curr Sci 1999; 77 (5): 658–666.
   Web of Science ®Google Scholar
• Valk EEJ, Hornstra G. Relationship between vitamin E requirement and polyunsaturated fatty acid intake in man: a review. J Vit Nutr Res 2000; 70 (2): 31–42.
   PubMed Web of Science ®Google Scholar
• Odeleye OE, Eskelson CD, Mufti SI, Watson RR. Vitamin E protection against nitrosamine-induced oesophageal tumor incidence in immunocompromised mice by retroviral infection. Carcinogenesis 1992; 13: 1811–1816.
   PubMed Web of Science ®Google Scholar
• Yano T, Ishikawa G, Ichikawa T. Is vitamin E a useful agent to protect against oxy radical-promoted lung tumorigen-esis in ddY mice? Carcinogenesis 1993; 14 (6): 1133-1136.
   Google Scholar
• Portal BC, Richard MJ, Faure HS, Hadjian AJ, Favier AE. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr 1995; 61: 843–847.
   PubMed Web of Science ®Google Scholar
• Winklhofer-Roob BM, Vant Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-a-tocopherol compared with all-rac-a-toco-pheryl acetate preparations. Am J Clin Nutr 1996; 63: 722–728.
   PubMed Web of Science ®Google Scholar
• Rouhiainen P, Rouhiainen H, Salonen J. Association between low plasma vitamin E concentration and progression of early cortical lens opacities. Am J Epidemiol 1996; 144 (5): 496–500.
   PubMed Web of Science ®Google Scholar
• Paolisso G, Gambradella A, Giugliano D, et al. Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr 1995; 61: 848–852.
   PubMed Web of Science ®Google Scholar
• Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vit-amin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The established popu-lations for epidemiologic studies of the elderly. Am J Clin Nutr 1996; 64: 190–196.
   PubMed Web of Science ®Google Scholar
• Suring JE, Hennekens CH. Antioxidant vitamins and cardiovascular disease. Nutr Rev 1997; 55 (1): S53–S60.
   Web of Science ®Google Scholar
• Selvam R, Ravichandran V. Restoration of tissue antiox-idants and prevention of renal stone deposition in vitamin B6 deficient rats fed with vitamin E or methionine. Ind J Exp Biol 1993; 31: 882–887.
   PubMedGoogle Scholar
• Ingles SA, Bird CL, Shikany JM, Frankl HD, Lee ER, Haile RW. Plasma tocopherol and prevalence of colorectal adenomas in a multiethnic population. Mutat Res 1998; 58: 661–666.
   Google Scholar
• Turley JM, Fu T, Rusutti FW, Mikovits JA, Bertolette DC, Birchenall-Roberts MC. Vitamin E succinate induces Fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Res 1997; 57 (5): 881–890.
   PubMed Web of Science ®Google Scholar
• Saintot M, Mathieu-Daude H, Astre C, et al. Oxidant-antioxidant status in relation to survival among breast cancer patients. Int J Cancer 2002; 97: 574–579.
   PubMed Web of Science ®Google Scholar
• Wolf G. a-Tocopherol: An efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr Rev 1997; 55 (10): 376–378.
   PubMed Web of Science ®Google Scholar
• Topinka L, Binkova B, Sram RJ, Erin AN. The influ-ence of a-tocopherol and pyritinol on oxidative DNA damage and lipid peroxidation in human lymphocytes. Mutat Res 1989; 225: 131–136.
   PubMed Web of Science ®Google Scholar
• Mitchel REJ, McCann R. Vitamin E is a complete tumor promoter in mouse skin. Carcinogenesis 1993; 14 (4): 659–662.
   PubMed Web of Science ®Google Scholar
• Gabhart E, Wagner H, Griziwok K, Behnsen H. The action of anticlastogens in human lymphocyte cultures and their modification by rat-liver S9 mix. Studies with vitamin C and E. Mutat Res 1985; 149: 83–94.
   PubMed Web of Science ®Google Scholar
• Lehr H, Vajkoczy P, Menger MD, Arfors KE. Do vita-min E supplements in diets for laboratory animals jeopardize findings in animal models of disease? Free Radical Biol Med 1999; 26(3/4): 472-481.
   Google Scholar
• Gerrish KE, Gensler HL. Prevention of photocarcino-genesis by dietary vitamin E. Nutr Cancer 1993; 19: 125–133.
   PubMed Web of Science ®Google Scholar
• Marcus R, Coulston AM. The vitamins. In: Goodman Gilman A, Rail TW, Nies AS, Taylor T. eds. Goodman & Gilman's: The pharmacological basis of therapeutics. McGraw-Hill International Edition 1992; 1&2: 1523-1571.
   Google Scholar